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An association of cigarette smoking with breast cancer risk has been hypothesized. However, results from previous
studies have been inconsistent. This case-control study investigated the association of cigarette smoking with breast
cancer risk in terms of estrogen-receptor/progesterone-receptor (ER/PgR) status. From among female patients aged
30 years and over admitted to a single hospital in Japan between 1997 and 2011, 1,263 breast cancer cases (672 ER
+/PgR+, 158 ER+/PgR-, 22 ER-/PgR+, 308 ER-/PgR- and 103 missing) and 3,160 controls were selected. History of
smoking (ever, never), some smoking-related measures, and passive smoking from husbands (ever, never) were
assessed using a self-administered questionnaire. Polytomous logistic regression and tests for heterogeneity across
ER+/PgR + and ER-/PgR- were conducted. For any hormone receptor subtype, no significant association was
observed between history of smoking (ever, never) and breast cancer risk. Analysis of smoking-related measures
revealed that starting to smoke at an early age of ≤19 years was significantly associated with an increased risk of
postmenopausal ER-/PgR- cancer (odds ratio = 7.01, 95% confidence interval: 2.07-23.73). Other measures of smoking
such as the number of cigarettes per day, the duration of smoking, and start of smoking before the first birth were
not associated with breast cancer risk for any receptor subtype. There was no association between passive smoking
(ever, never) and breast cancer risk for any of the four subtypes. These results indicate that history of smoking and
passive smoking from husbands may have no overall effect on breast cancer risk for any hormone receptor subtype.
However, it is possible that women who start to smoke as teenagers may have a higher risk of developing
postmenopausal ER-/PgR- cancer. Further studies are needed to clarify the association of smoking with breast
cancer risk, especially the role of starting to smoke at an early age.
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Breast cancer is one of the most common cancers world-
wide (Curado et al. 2007). Although Japan has a lower risk
of breast cancer in comparison with Western countries,
its incidence is first in terms of age-standardized rates
among all female cancers, and it is increasing continu-
ously (Matsuda et al. 2012; Minami et al. 2004). The estab-
lished risk factors for breast cancer include menstrual and* Correspondence: adym@med.tohoku.ac.jp
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in any medium, provided the original work is preproductive history, family history of breast cancer, some
anthropometric measures such as tallness and postmeno-
pausal obesity, and alcohol consumption (Kelsey et al.
1993; Kawai et al. 2010; Pharoah et al. 1997; Renehan
et al. 2008; van den Brandt et al. 2000; Key et al. 2006).
Most of these risk factors are not preventable.
Cigarette smoking is known to be a preventable risk fac-
tor for cancer including several major sites such as the
lung and stomach (Minami and Tateno 2003; Katanoda
et al. 2008). An association of cigarette smoking with
breast cancer risk has also been hypothesized (Palmer and
Rosenberg 1993), and numerous epidemiologic studies
have investigated this issue. However, the results have
been less consistent compared with those for otheran Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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analysis of 53 epidemiologic studies (Hamajima et al.
2002) has showed that smoking was not associated with
breast cancer risk, whereas a review by Terry and Rohan
suggested an increased risk of breast cancer among
women with specific characteristics such as smoking of
long duration (Terry and Rohan 2002). A recent report
from Canada indicated a positive association between ac-
tive smoking and breast cancer risk (Johnson et al. 2011).
The IARC Monograph in 2012 suggests the positive asso-
ciation, although evidence is limited (International Agency
for Research on Cancer 2012; Secretan et al. 2009). In
Japan, a systematic review including three cohort studies
and eight case-control studies concluded that smoking
possibly increases breast cancer risk (Nagata et al. 2006);
however, only a few studies have demonstrated a signifi-
cant association between smoking and an increased risk of
breast cancer (Hanaoka et al. 2005).
From the viewpoint of biological mechanisms, the re-
lationship between cigarette smoking and the develop-
ment of breast cancer is likely a complex one. Tobacco
smoke contains potential human breast carcinogens such
as polycyclic aromatic hydrocarbons, aromatic amines,
and N-nitrosamine (Zaridze and Peto 1986). These car-
cinogens may induce mammary tumors (Hecht 2002).
Conversely, smoking has been postulated to have an anti-
estrogenic effect, which may also affect the development
of breast cancer (Baron 1984; Tanko and Christiansen
2004). Taking into account these biological characteristics
of cigarette smoke, its association with breast cancer risk
may differ according to menopausal status and hormone
receptor status. However, most studies have evaluated the
overall association between cigarette smoking and the risk
of breast cancer, which may account for the inconsistency
in the results mentioned above. Few studies have focused
on breast cancer risk with reference to hormone receptor
status (Yoo et al. 1997; Manjer et al. 2001; Gammon et al.
2004; Luo et al. 2011).
To clarify the association of cigarette smoking with
breast cancer risk according to menopausal status and
hormone receptor status, we conducted a hospital-based
case-control study. Data were obtained from women
aged 30 years and over who were admitted to a single
hospital in Miyagi Prefecture, Japan, between 1997 and
2011. Analyses were performed with reference to joint
estrogen-receptor/progesterone-receptor (ER/PgR) sta-
tus, i.e., ER+/PgR+, ER+/PgR-, ER-/PgR+, and ER-/PgR-.
Methods
Data collection
In January 1997, we began a questionnaire survey in
connection with the present study. Information on life-
style and personal history was collected from all patients
at their first admission to the Miyagi Cancer CenterHospital (MCCH), using a self-administered question-
naire. The questionnaire was distributed to patients on
the day of their reservation for initial admission, i.e., 10-
15 days before admission, and collected by nurses on the
day of actual admission. The purpose of the survey was
stated on the cover page of the questionnaire. We con-
sidered the return of self-administered questionnaires
signed by the patients to imply their consent to partici-
pate in the study.
The MCCH is located in the southern part of Miyagi
Prefecture, and functions as a hospital for both cancer
and benign diseases. Details of the questionnaire survey
have already been described elsewhere (Minami and
Tateno 2003; Minami et al. 2012; Kawai et al. 2012; Seki
et al. 2013).
The questionnaire covered demographic characteris-
tics, personal and family histories of cancer and other
diseases including a family history of breast cancer in
mother or sisters, general lifestyle factors before the de-
velopment of current symptoms, including cigarette
smoking, alcohol drinking, exercise, occupation, men-
strual and reproductive histories, and histories of oral
contraceptive (OC) use and exogenous female hormone
use. Items related to the referral status and area of resi-
dence were also included. Between January 1997 and
December 2011, the questionnaire was distributed to
26,984 first-admitted patients, of whom 24,062 responded.
Study subjects
Cases and controls were selected from among 24,062 pa-
tients who responded to the questionnaire survey. To
identify incident cases of female breast cancer, a list of
the patients was linked with both the hospital-based
cancer registry file and the disease registration database
at MCCH. The cancer registry records all cancer cases
confirmed by clinical, cytological and/or histopatho-
logical examination at the MCCH. Through the linkage,
24,062 patients were classified into 2,219 with a past his-
tory of cancer, 7,707 males with cancer, 1,309 females
with breast cancer, 4,779 females with other cancers,
and 8,048 non-cancer patients (4,170 males and 3,878
females). Among the 1,309 females with breast cancer,
1,302 aged 30 years and over were included as the study
cases.
Controls were selected from among female non-cancer
patients without history of cancer (n = 3,878). Patients
with benign tumors have been classified as non-cancer
patients for the present study. After excluding patients
under 30 years, 3,587 female non-cancer patients aged
30 years and over were selected as possible controls,
from whom 295 subjects with smoking-related disease
were excluded. Finally, a total of 3,292 female non-
cancer patients were included as controls. Smoking-
related diseases were defined based on the procedure
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Seki et al. 2013). The diagnoses among the 295 excluded
subjects were heart disease in 118, respiratory disease in
130, and benign tumors including the upper respiratory
tract in 18, esophagus in 10 and urinary tract in 19. The
diagnoses among the 3,292 controls were as follows: be-
nign tumor 2,083 (63.3%), digestive tract disease 403
(12.2%), urologic-gynecologic disease 176 (5.4%), endo-
crine or metabolic disease 87 (2.6%), orthopedic disorder
54 (1.6%), other benign disease 207 (6.3%), and no ab-
normal findings 282 (8.6%). The sites of benign tumors
were stomach in 156 subjects, colorectum in 532, lung
in 21, breast in 44, gynecologic organs in 381, bone or
connective tissue in 636, and other in 313.
This study was approved by the ethical review board
of the Miyagi Cancer Center.
The final response rate for the questionnaire survey
was 94.4% for the cases and 89.6% for the possible
controls.
Assessment of cigarette smoking
Information on exposure, i.e., cigarette smoking, was
collected from the above questionnaire survey. Exposure
variables related to active smoking included history of
smoking (never-, past-, current-smoker), age at the start
of smoking (never, ≤19, ≥20- ≤ 25, ≥26 yr), whether
smoking had started before the first birth (never, no, yes,
uncertain), duration of smoking (never, >0- ≤ 21, >21),
the mean number of cigarettes smoked per day during
the smoking period (never, >0- ≤ 10, ≥11 yr), and the
number of pack-years of smoking (never, >0- ≤ 13, >13).
Subjects who quit smoking within one year before the
present admission were regarded as current smokers.
Pack-years of smoking were calculated by multiplying
the duration of smoking by the mean number of ciga-
rettes smoked per day divided by 20. Whether smoking
had started before the first birth was defined by compar-
ing the age at the start of smoking and the age at first
birth. When age at the start of smoking was equal to the
age at first birth, the case was assigned to the “uncer-
tain” category. Cut-off points for age at the start of
smoking were determined arbitrarily, considering the
importance of the category for subjects who started
smoking as teenagers. For the other three exposure vari-
ables, the mid-point among the controls was used as a
cut-off point. Subjects for whom data on smoking his-
tory were missing [n = 39 (3.0%) for cases and n = 132
(4.0%) for controls] were excluded from the subsequent
analysis, leaving 1,263 cases and 3,160 controls.
The only exposure variable related to passive smoking
was the husband’s smoking status (never-, past-, current-
smoker). This information was obtained from married
subjects. The risk for passive smoking was investigated
only among never-smokers.Hormone receptor status
Information on the expression of ER and PgR in breast
cancers was extracted from medical records. To measure
ER/PgR status, enzyme immunoassay (EIA) had been used
in the early period of the study to determine hormone
receptor status. After mid-2003, immunohistochemistry
(IHC) assay was routinely conducted. The concordance be-
tween the two assays was 94.3% for ER and 100% for PgR
in the laboratory of the MCCH (Kakugawa et al. 2007).
Statistical analysis
We used multiple polytomous unconditional logistic re-
gression analysis to estimate hormone receptor-defined
breast cancer risk. In the analysis, study subjects were
categorized using the cut-off points for each exposure
and odds ratios (ORs) and 95% confidence intervals
(CIs) were calculated for each category.
We considered the following variables to be potential
confounders: age, year of recruitment, referral status (from
screening, other), area of residence (Southern Miyagi pre-
fecture, others), alcohol drinking (ever, never), occupation
(professional or clerical work, industrial work or fishery,
agriculture or forestry, other), age at menarche, age at
menopause, menopausal status (premenopausal, postmen-
opausal), reason for menopause (natural menopause,
menopause for other reasons), parity number, age at first
birth, family history of breast cancer in mother or sisters
(yes, no), physical activity (almost no, more than one hour
per week), body mass index (BMI), and history of use of
exogenous female hormones or OCs (ever, never). Occu-
pation classification was based on the categorization used
in our previous study (Seki et al. 2013). Missing values
were treated as an additional variable category.
We stratified case subjects according to joint hormone
receptor status: ER+/PgR+, ER+/PgR-, ER-/PgR+, and
ER-/PgR-. Stratification by menopausal status was also
performed. Menopause was defined as the cessation of
menstrual periods due to natural or other reasons, in-
cluding surgery (Kawai et al. 2012). In the analysis strati-
fied by menopausal status, we excluded cases with ER
+/PgR- or ER-/PgR + tumors because these were too few
to allow precise estimation of ORs in comparison with
subjects who had ER+/PgR + or ER-/PgR- tumors.
Dose-response relationships were tested by treating each
exposure category as a continuous variable. We conducted
Wald tests for heterogeneity of breast cancer risk across
ER+/PgR + and ER-/PgR-. Values were regarded as signifi-
cant if the two-sided P values were <0.05. All analyses
were performed using SAS version 9.3 (SAS Institute,
Cary, NC).
Results
The baseline characteristics of the study subjects are pre-
sented in Table 1. Joint ER/PgR status was available for
Table 1 Characteristics of cases and controls by hormone receptor status
Cases Controls
Hormone receptor
ER+/PgR+ ER+/PgR- ER-/PgR+ ER-/PgR- Missing
Number of subjects 672 158 22 308 103 3160
Age group (years old) (%)
30-39 6.4 3.2 9.1 4.9 9.7 9.7
40-49 26.5 17.1 45.5 22.4 12.6 17.8
50-59 27.8 28.5 22.7 30.8 35.0 22.1
60-69 22.9 32.9 13.6 23.1 18.5 25.2
70 ≤ 16.4 18.4 9.1 18.8 24.3 25.3
Mean (years old) 56.7 59.5 52.3 57.8 58.7 59.0
SD 12.4 11.1 11.7 12.1 13.2 13.9
Menopausal status (%)a
Premenopausal 41.1 22.2 45.5 29.9 23.3 29.6
Postmenopausal 54.4 74.0 40.9 63.3 46.6 65.1
Unknown menopausal status 4.5 3.8 13.6 6.8 30.1 5.3
Year of recruitment (%)
1997-2003 30.1 38.0 54.6 42.9 52.4 52.7
2004-2011 69.9 62.0 45.5 57.1 47.6 47.3
Referrel status (%)
From screening 21.7 20.3 18.2 15.3 7.8 18.2
Other 78.3 79.8 81.8 84.7 92.2 81.8
Area of residence (%)
Southern Miyagi prefecture 83.5 85.4 81.8 82.8 79.6 88.3
Other area 16.5 14.6 18.2 17.2 20.4 11.7
Occupation (%)
Agriculture or forestry 5.1 3.8 9.1 6.2 6.8 9.1
Industrial work or fishery 16.5 12.7 9.1 19.8 10.7 14.3
Professional or clerical work 45.2 46.8 40.9 37.7 33.0 36.0
Otherb 22.2 26.6 27.3 23.7 30.1 24.5
Missing 11.0 10.1 13.6 12.7 19.4 16.0
BMI (kg/m2, %)
< 18.5 5.1 6.3 - 5.2 9.7 5.9
18.5 ≤ < 25.0 59.4 63.9 59.1 66.6 62.1 63.9
25.0 ≤ < 30.0 26.8 24.7 40.9 22.4 21.4 25.3
30.0 ≤ 8.3 5.1 - 5.5 3.9 4.0
Missing 0.5 - - 0.3 2.9 1.0
Mean 24.0 23.5 24.2 23.3 23.0 23.4
SD 3.8 3.7 3.2 3.9 3.5 3.5
Time spent exercising (%)
Almost no 50.5 49.4 45.5 51.3 50.5 48.6
1≤ hr per week 44.1 43.7 50.0 41.6 38.8 45.2
Missing 5.5 7.0 4.6 7.1 10.7 6.2
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Table 1 Characteristics of cases and controls by hormone receptor status (Continued)
Age at menarche (%)
≤ 12 33.8 20.9 36.4 30.2 28.2 23.3
13 22.8 21.5 22.7 22.1 20.4 19.9
14 19.1 27.9 18.2 20.8 16.5 18.9
15 ≤ 20.8 25.3 18.2 22.7 26.2 30.8
Missing 3.6 4.4 4.6 4.2 8.7 7.1
Age at menopause (%)
< 48 12.3 6.0 22.2 11.8 18.8 12.5
48 ≤ < 51 30.6 29.9 22.2 24.1 41.7 26.9
51 ≤ < 54 18.6 27.4 33.3 25.1 27.1 19.7
54 ≤ 13.9 15.4 11.1 12.3 12.5 8.7
Missing 24.6 21.4 11.1 26.7 0.0 32.2
Parity number (%)
0 12.1 7.6 4.6 6.2 11.7 7.9
1 10.4 9.5 18.2 13.3 8.7 9.1
2 45.5 43.7 59.1 44.8 42.7 40.8
3 ≤ 24.4 29.1 9.1 28.6 27.2 33.3
Missing 7.6 10.1 9.1 7.1 9.7 9.1
Age at first birth (%)
≤ 24 31.9 38.6 9.1 37.7 36.9 41.1
25 ≤ ≤ 29 39.1 36.7 59.1 39.0 35.9 35.8
30 ≤ ≤ 50 11.2 11.4 18.2 11.0 6.8 7.3
Missing 17.9 13.3 13.6 12.3 20.4 15.9
Use of exogenous female hormone or oral contraceptives (%)
Never 81.1 79.8 90.9 83.1 76.7 78.7
Ever or current 9.8 12.0 90.9 9.7 11.7 9.1
Missing 9.1 8.2 90.9 7.1 11.7 12.3
Family history of breast cancer in mother or sister (%)
No 90.8 87.3 81.8 88.6 94.2 96.0
Yes 9.2 12.7 18.2 11.4 5.8 4.0
Alcohol drinking (%)
Never 67.6 79.8 77.3 70.5 75.7 72.6
Current or past 30.1 20.3 18.2 27.3 18.5 24.4
Missing 2.4 - 4.6 2.3 5.8 3.0
Smoking status (%)
Never 82.6 81.7 77.3 83.1 82.5 83.2
Current 12.5 11.4 13.6 12.3 12.6 12.9
Past 4.9 7.0 9.1 4.6 4.9 3.9
Passive smoking (%)
Number of subjectsc 499 116 17 241 77 2405
Never 30.1 31.0 41.2 30.3 23.4 30.9
Past 23.9 21.6 - 19.9 14.3 20.3
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Current 35.3 31.0 52.9 39.0 48.1 34.4
Missing 10.8 16a.4 5.9 10.8 14.3 14.5
aMenopause was defined as the cessation of menstrual periods due to natural or other reasons including surgery.
bHousehold wife/Domestic help/Student/Other.
cHusband’s smoking among never-smoking married women.
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+/PgR-, 22 were ER-/PgR+, and 308 were ER-/PgR-. Cases
with ER-/PgR- tumors were less likely to have been re-
ferred from screening. Those with ER+/PgR + tumors
were more likely to be heavier, and to be nulliparous.
Table 2 shows ORs and 95% CIs for exposure variables
related to active smoking according to the four hormone
receptor subtypes. No association between history of
smoking (ever, never) and breast cancer risk was ob-
served for either ER+/PgR + or ER-/PgR- type. For both
ER+/PgR- and ER-/PgR + types, the OR for past smoking
exceeded one; however, statistical test showed that this
was not significant. Age at the start of smoking was not
significantly associated with breast cancer risk for any of
the subtypes, although the risk for the ER-/PgR + type
was not fully evaluated due to the small number of
cases. An increased risk for starting to smoke at an earl-
ier age (OR = 1.55, 95%CI: 0.76-3.20 for ≤19 years) was
observed for the ER-/PgR- type, but this was not statisti-
cally significant. There was no association between hav-
ing started smoking before the first birth and breast
cancer risk for any of the subtypes. Analyses of the num-
ber of cigarettes smoked per day, the duration of smok-
ing, and the number of pack-years demonstrated no
significant association between these exposure variables
and the risk for any subtype of breast cancer.
Table 3 shows the results for premenopausal women
according to ER+/PgR + and ER-/PgR- status. History of
smoking was not associated with breast cancer risk for
any of the tumor subtypes. No association with breast
cancer risk was also observed for age at the start of
smoking, start of smoking before the first birth, the
number of cigarettes smoked per day, and duration of
smoking.
Table 4 shows the results according to ER+/PgR + and
ER-/PgR- status among postmenopausal women. For
both subtypes, no association with history of smoking
was observed. However, an extremely high risk for ER-/
PgR- cancer was found for start of smoking at an early
age (OR = 7.01, 95%CI: 2.07-23.73 for ≤19 years), al-
though the confidence interval for this category was
wide, and the trend test for age at the start of smoking
failed to demonstrate any significance (Ptrend = 0.71). No
other exposure variables were associated with breast
cancer risk for either of the hormone receptor subtypes.
Tables 5 and 6 show the association with passive
smoking. Overall analysis demonstrated no associationbetween passive smoking and breast cancer risk for any
of the four tumor subtypes, although the risk of the ER-/
PgR + type may have been uncertain due to the small
number of cases (Table 5). On the basis of menopausal
status, passive smoking was not associated with either
ER+/PgR + or ER-/PgR- tumor type in either pre- or
post-menopausal women (Table 6).
Discussion
This hospital-based case-control study was designed to
investigate the association between smoking and breast
cancer risk in relation to joint hormone receptor status.
The risks for history of smoking (ever, never) and vari-
ous smoking-related measures, including age at the start
of smoking, whether an individual started smoking be-
fore her first birth, the number of cigarettes smoked per
day, the duration of smoking, and the number of pack-
years, and passive smoking from husbands (ever, never)
were evaluated, and analysis based on menopausal status
was also performed. Evidence for smoking-related breast
cancer risk in relation to hormone receptor subtype has
been limited in both Japan and Western countries (Terry
and Rohan 2002; Althuis et al. 2004). Therefore, our re-
sult is important for helping to clarify the impact of
smoking on breast cancer risk.
Although the results from previous studies have been
inconsistent with regard to the overall association be-
tween smoking and breast cancer risk (Hamajima et al.
2002; Terry and Rohan 2002; Johnson et al. 2011; Inter-
national Agency for Research on Cancer 2012; Nagata
et al. 2006), those related to hormone receptor status
have also been inconsistent. Some studies have reported
a positive association between ever smoking and the risk
of ER + cancer (Yoo et al. 1997; London et al. 1989;
Morabia et al. 1998; Gaudet et al. 2013), whereas others
have reported a positive association for ER- cancer, or
no association (Morabia et al. 1998; Cooper et al. 1989).
Although studies focusing on PgR have been few, a co-
hort study by Manjer et al. found an increased risk of
PgR- cancer among ex-smokers and an increased risk of
ER-/PgR- cancer among current or ex-smokers (Manjer
et al. 2001). In contrast, a case-control study from Japan
reported that ever smoking was associated with an in-
creased risk of PgR + cancer (Yoo et al. 1997). A recent
cohort study from the US demonstrated a positive asso-
ciation between smoking and the risk of ER+/PgR + can-
cer among postmenopausal women (Luo et al. 2011).
Table 2 Odds ratio (OR) according to smoking status by hormone receptor status
ER+/PgR+ (n = 672) ER+/PgR- (n = 158) ER-/PgR+ (n = 22) ER-/PgR- (n = 308) Pheterogeneity
Controls Cases OR 95% CI p Cases OR 95% CI p Cases OR 95% CI p Cases OR 95% CI p ER+/PgR+ vs ER-/PgR-
History of smoking
Never smoker 2629 555 1 (Reference) 129 1 (Reference) 17 1 (Reference) 256 1 (Reference)
Current 408 84 0.86 0.65 - 1.14 18 0.99 0.58 - 1.69 3 1.06 0.28 - 4.12 38 0.84 0.57 - 1.23
Past 123 33 0.92 0.60 - 1.41 11 1.80 0.92 - 3.53 2 2.53 0.49 - 12.96 14 1.02 0.57 - 1.83
Ever 531 117 0.88 0.68 - 1.12 29 1.20 0.76 - 1.88 5 1.40 0.45 - 4.32 52 0.88 0.63 - 1.24 0.96
Age at the start of smoking (years)
Never smoker 2629 555 1 (Reference) 129 1 (Reference) 17 1 (Reference) 256 1 (Reference)
26 ≤ 166 28 0.85 0.55 - 1.31 10 1.22 0.61 - 2.43 0 - - - - 13 0.73 0.40 - 1.33
20 ≤ ≤ 25 253 63 0.90 0.65 - 1.24 12 1.01 0.52 - 1.94 4 2.12 0.60 - 7.51 25 0.89 0.56 - 1.41
≤ 19 60 16 0.91 0.49 - 1.67 2 0.83 0.19 - 3.59 0 - - - - 10 1.55 0.76 - 3.20
p for trend 0.42 0.94 0.58 0.95 0.57
Smoking started before first birth
Never smoker 2629 555 1 (Reference) 129 1 (Reference) 17 1 (Reference) 256 1 (Reference)
No 179 30 0.86 0.56 - 1.31 9 0.99 0.48 - 2.03 - - - - - 14 0.70 0.40 - 1.26
Yes 193 53 0.95 0.67 - 1.35 12 1.36 0.70 - 2.65 4 2.30 0.63 - 8.38 23 0.97 0.60 - 1.59
Uncertain 27 6 1.02 0.40 - 2.62 1 0.96 0.13 - 7.39 - - - - - 3 0.97 0.28 - 3.31
Number of cigarettes per day
Never smoker 2629 555 1 (Reference) 129 1 (Reference) 17 1 (Reference) 256 1 (Reference)
0 < ≤ 10 255 58 0.87 0.62 - 1.20 13 1.12 0.60 - 2.09 3 1.90 0.47 - 7.71 22 0.77 0.48 - 1.25
11 ≤ 229 51 0.92 0.65 - 1.30 11 1.01 0.52 - 1.97 1 0.61 0.07 - 5.15 25 0.99 0.63 - 1.56
p for trend 0.47 0.87 0.94 0.68 0.92
Duration of smoking (years)
Never smoker 2629 555 1 (Reference) 129 1 (Reference) 17 1 (Reference) 256 1 (Reference)
0 < ≤ 21 242 48 0.70 0.49 - 1.00 11 1.02 0.52 - 2.02 2 1.07 0.21 - 5.50 21 0.78 0.47 - 1.29
21 < 226 52 1.00 0.71 - 1.40 12 1.09 0.58 - 2.06 2 1.52 0.31 - 7.41 25 1.01 0.64 - 1.59















Table 2 Odds ratio (OR) according to smoking status by hormone receptor status (Continued)
Pack-years
Never smoker 2629 555 1 (Reference) 129 1 (Reference) 17 1 (Reference) 256 1 (Reference)
0 < ≤ 13 238 48 0.71 0.50 - 1.02 12 1.18 0.61 - 2.27 3 1.67 0.41 - 6.86 17 0.63 0.37 - 1.09
13 < 225 52 1.01 0.72 - 1.42 10 0.89 0.45 - 1.76 1 0.75 0.09 - 6.24 28 1.13 0.73 - 1.75
p for trend 0.54 0.88 0.94 0.97 0.71
All models were adjusted by age (continuous), BMI (< 18.5, 18.5 ≤ < 25.0, 25.0 ≤ < 30.0, 30.0 ≤), occupation (professional or clerical work, industrial work or fishery, agriculture or forestry, other), physical activity (almost no,
more than one hour per week), menopausal status (premenopausal, postmenopausal), age at menarche (≤ 12, 13, 14, 15 ≤), age at menopause (< 48, 48 ≤ < 51, 51 ≤ < 54, 54 ≤), age at first birth (≤ 24, 25 ≤ ≤ 29, 30 ≤ ≤ 50),
family history of breast cancer in mother or sister (yes, no), parity number (0, 1, 2, 3 ≤), use of exogenous female hormone or oral contraceptives (yes, no), referrel status (from screening, other), year of recruitment















Table 3 Odds ratio (OR) among premenopausal women according to smoking status by hormone receptor status
Premenopausal
Controls
ER+/PgR+ (n = 276) ER-/PgR- (n = 92)
PheterogeneityCases OR 95% CI p Cases OR 95% CI p
History of smoking
Never smoker 668 204 1 (Reference) 69 1 (Reference)
Current 220 51 0.89 0.60 - 1.32 20 0.92 0.52 - 1.64
Past 49 21 1.09 0.59 - 2.02 3 0.49 0.14 - 1.69
Ever 269 72 0.94 0.65 - 1.34 23 0.82 0.48 - 1.42 0.67
Age at the start of smoking (years)
Never smoker 668 204 1 (Reference) 69 1 (Reference)
26 ≤ 42 12 1.19 0.57 - 2.47 3 0.61 0.18 - 2.12
20 ≤ ≤ 25 167 40 0.80 0.52 - 1.24 16 0.93 0.50 - 1.74
≤ 19 47 15 1.12 0.56 - 2.26 4 0.83 0.27 - 2.54
p for trend 0.65 0.68 0.92
Smoking started before first birth
Never smoker 668 204 1 (Reference) 69 1 (Reference)
No 56 12 0.75 0.36 - 1.57 3 0.43 0.12 - 1.48
Yes 136 39 0.94 0.59 - 1.50 14 0.93 0.47 - 1.81
Uncertain 14 4 0.95 0.28 - 3.23 2 1.15 0.23 - 5.63
Number of cigarettets per day
Never smoker 668 204 1 (Reference) 69 1 (Reference)
0 < ≤ 10 139 38 0.93 0.59 - 1.46 11 0.72 0.35 - 1.48
11 ≤ 118 30 0.92 0.56 - 1.50 11 0.87 0.42 - 1.78
p for trend 0.68 0.53 0.75
Duration of smoking (years)
Never smoker 668 204 1 (Reference) 69 1 (Reference)
0 < ≤ 21 184 40 0.93 0.60 - 1.46 11 0.71 0.34 - 1.47
21 < 69 23 0.79 0.45 - 1.39 10 0.94 0.44 - 2.01
p for trend 0.41 0.63 0.93
Pack-years
Never smoker 668 204 1 (Reference) 69 1 (Reference)
0 < ≤ 13 165 37 0.82 0.52 - 1.29 9 0.56 0.26 - 1.21
13 < 86 26 0.98 0.58 - 1.66 11 1.06 0.51 - 2.22
p for trend 0.68 0.69 0.91
All models were adjusted by age (continuous), BMI (< 18.5, 18.5 ≤ < 25.0, 25.0 ≤ < 30.0, 30.0 ≤), occupation (professional or clerical work, industrial work or
fishery, agriculture or forestry, other), physical activity (almost no, more than one hour per week), age at menarche (≤ 12, 13, 14, 15 ≤), age at first birth (≤ 24,
25 ≤ ≤ 29, 30 ≤ ≤ 50), family history of breast cancer in mother or sister (yes, no), parity number (0, 1, 2, 3 ≤), use of exogenous female hormone or oral
contraceptives (yes, no), referrel status (from screening, other), year of recruitment (continuous), area of residence (Southern Miyagi prefecture, other area) and
alcohol drinking (never, current or past).
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http://www.springerplus.com/content/3/1/65The present study found that history of smoking (ever,
never) had no overall effect on breast cancer risk for any
hormone receptor subtype. However, a few smoking-
related measures were associated with the risk of ER-/
PgR- cancer: the analysis for all subjects showed that
having started to smoke at an early age of ≤19 years was
associated with an increased risk of ER-/PgR- cancer, al-
though this did not reach statistically significance. Ac-
cording to menopausal status, starting to smoke at anearly age of ≤19 years was significantly associated with
an increased risk of postmenopausal ER-/PgR- cancer, al-
though there was no linear relationship between age at
the start of smoking and the risk of ER-/PgR- cancer.
On other hand, no smoking-related measure was found
to be associated with the risk of ER+/PgR + cancer in ei-
ther pre- or postmenopausal women. Although the
significant association of an early age at the start of
smoking with the risk of postmenopausal ER-/PgR-
Table 4 Odds ratio (OR) among postmenopausal women according to smoking status by hormone receptor status
Postmenopausal
Controls
ER+/PgR+ (n = 366) ER-/PgR- (n = 195) Pheterogeneity
Cases OR 95% CI p Cases OR 95% CI p
History of smoking
Never smoker 1829 327 1 (Reference) 172 1 (Reference)
Current 161 29 0.96 0.61 - 1.52 14 0.74 0.41 - 1.35
Past 66 10 0.67 0.33 - 1.38 9 1.25 0.59 - 2.64
Ever 227 39 0.87 0.58 - 1.29 23 0.88 0.55 - 1.44 0.95
Age at the start of smoking (years)
Never smoker 1829 327 1 (Reference) 172 1 (Reference)
26 ≤ 113 14 0.69 0.38 - 1.25 10 0.87 0.44 - 1.75
20 ≤ ≤ 25 72 20 1.30 0.74 - 2.31 5 0.52 0.20 - 1.34
≤ 19 8 0 - - - - 5 7.01 2.07 - 23.73
p for trend - 0.71 -
Smoking started before first birth
Never smoker 1829 327 1 (Reference) 172 1 (Reference)
No 112 16 0.81 0.46 - 1.44 10 0.83 0.42 - 1.67
Yes 51 12 1.06 0.53 - 2.10 8 1.17 0.52 - 2.61
Uncertain 9 2 1.28 0.23 - 7.28 0 - - - -
Number of cigarettes per day
Never smoker 1829 327 1 (Reference) 172 1 (Reference)
0 < ≤ 10 108 16 0.74 0.41 - 1.33 7 0.56 0.25 - 1.26
11 ≤ 88 19 1.14 0.65 - 1.98 13 1.35 0.72 - 2.55
p for trend 0.99 0.79 0.82
Duration of smoking (years)
Never smoker 1829 327 1 (Reference) 172 1 (Reference)
0 < ≤ 21 48 7 0.69 0.30 - 1.62 8 1.36 0.61 - 3.03
21 < 138 25 0.93 0.57 - 1.50 12 0.78 0.41 - 1.49
p for trend 0.62 0.61 0.92
Pack-years
Never smoker 1829 327 1 (Reference) 172 1 (Reference)
0 < ≤ 13 65 9 0.67 0.31 - 1.43 6 0.76 0.31 - 1.83
13 < 118 23 1.01 0.61 - 1.67 14 1.09 0.59 - 2.00
p for trend 0.78 0.94 0.80
All models were adjusted by age (continuous), BMI (< 18.5, 18.5 ≤ < 25.0, 25.0 ≤ < 30.0, 30.0 ≤), occupation (professional or clerical work, industrial work or
fishery, agriculture or forestry, other), physical activity (almost no, more than one hour per week), age at menarche (≤ 12, 13, 14, 15 ≤), age at menopause (< 48,
48 ≤ < 51, 51 ≤ < 54, 54 ≤), reson of menopause (natural, others including surgery), age at first birth (≤ 24, 25 ≤ ≤ 29, 30 ≤ ≤ 50), family history of breast cancer in
mother or sister (yes, no), parity number (0, 1, 2, 3 ≤), use of exogenous female hormone or oral contraceptives (yes, no), referrel status (from screening, other),
year of recruitment (continuous), area of residence (Southern Miyagi prefecture, other area) and alcohol drinking (never, current or past).
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http://www.springerplus.com/content/3/1/65cancer must be interpreted carefully because of the wide
confidence interval, this finding suggests that early ex-
posure to tobacco smoke may stimulate the development
of ER-/PgR- cancer. Cell-proliferative activity in the
breast is known to be very high during the teenage
period (Potten et al. 1988), and therefore during this
period breast tissue may be especially susceptible to to-
bacco smoke (Terry and Rohan 2002; Palmer et al.
1991). Furthermore, detailed analysis of our data foundthat postmenopausal ER-/PgR- cancer cases and controls
who starting smoking at ≤19 years tended to be heavy,
long-term smokers (data not shown). Thus, some sub-
jects with particular characteristics who start smoking as
teenagers may have a higher risk of developing postmen-
opausal ER-/PgR- cancer. To our knowledge, previous
studies have never evaluated the effect of age at the start
of smoking on ER-/PgR cancer risk. To confirm whether
age at the start of smoking is indeed related to the risk
Table 5 Odds ratio (OR) according to passive smoking by hormone receptor status
Controls ER+/PgR+ (n = 445) ER+/PgR- (n = 97) ER-/PgR+ (n = 16) ER-/PgR- (n = 215) Pheterogeneity
Cases OR 95% CI Cases OR 95% CI Cases OR 95% CI Cases OR 95% CI ER+/PgR+ vs
ER-/PgR-
Passive smoking (husband’s smoking)
Never
smoker
744 150 1 (Reference) 36 1 (Reference) 7 1 (Reference) 73 1 (Reference)
Current 826 176 1.13 0.88 - 1.47 36 0.99 0.60 - 1.61 9 1.72 0.56 - 5.27 94 1.17 0.83 - 1.63
Past 487 119 1.11 0.84 - 1.47 25 0.96 0.56 - 1.65 0 - - - - 48 0.93 0.63 - 1.38
Ever 1313 295 1.13 0.90 - 1.42 61 0.98 0.63 - 1.51 9 1.01 0.34 - 2.98 142 1.07 0.79 - 1.46 0.78
Analyzed for never-smoking married women.
Adjusted by age (continuous), BMI (< 18.5, 18.5 ≤ < 25.0, 25.0 ≤ < 30.0, 30.0 ≤), occupation (professional or clerical work, industrial work or fishery, agriculture or
forestry, other), physical activity (almost no, more than one hour per week), menopausal status (premenopausal, postmenopausal), age at menarche (≤ 12, 13, 14,
15 ≤), age at menopause (< 48, 48 ≤ < 51, 51 ≤ < 54, 54 ≤), age at first birth (≤ 24, 25 ≤ ≤ 29, 30 ≤ ≤ 50), family history of breast cancer in mother or sister (yes,
no), parity number (0, 1, 2, 3 ≤), use of exogenous female hormone or oral contraceptives (yes, no), referrel status (from screening, other), year of recruitment
(continuous), area of residence (Southern Miyagi prefecture, other area) and alcohol drinking (never, current or past).
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http://www.springerplus.com/content/3/1/65of ER-/PgR- cancer, further studies including cohort
studies are required.
The association of smoking with breast cancer risk ob-
served in previous studies has been explained from the
viewpoint of biological mechanisms. First, tobacco
smoke contains carcinogenic substances, which may in-
crease the risk of breast cancer regardless of hormone
receptor subtype (International Agency for Research on
Cancer 2012; Hecht 2002; Luo et al. 2011). Actually, me-
tabolites of tobacco smoke have been detected in the
breast fluid or tissues of smokers (Petrakis et al. 1978).
However, it has been demonstrated that specific geno-
types such as slow N-acetyltransferase 2 genotype affect
the enzyme activity for the detoxification of tobacco
smoke carcinogens (International Agency for Research
on Cancer 2012; Ambrosone et al. 2008; Zhang et al.
2010). The effects of tobacco carcinogens may modified
by polymorphism in some genes (International Agency
for Research on Cancer 2012; Ambrosone et al. 2008;
Zhang et al. 2010; Rabstein et al. 2010; Yang et al. 2007).
Second, antiestrogenic effects of smoking may affect the
risk of breast cancer (Baron 1984; Tanko and Christiansen
2004; MacMahon et al. 1982). The null association with
the risk of receptor-positive breast cancer demonstrated
in the present study may have been attributable to such
effects. However, the antiestrogenic effects of tobacco
smoke on breast cancer risk are not straightforward. A
review by Terry et al. indicated that such antiestrogenic
effects may be modified by some factors including ex-
ogenous female hormone use (Terry and Rohan 2002).
The difference in the results between studies conducted
in Japan and Western countries may be partly attributable
to differences in lifestyles among the study populations.
In Japan, far fewer women use exogenous female hor-
mones than in Western countries (IARC Working Group
on the Evaluation of Carcinogenic Risks to Humans
2007). Although we adjusted for the use of exogenousfemale hormones in our present statistical analysis, other
unspecified hormone-related factors might have con-
founded the association between smoking and breast can-
cer risk.
In relation to the breast cancer risk posed by passive
smoking, some previous studies, mainly case-control
studies, have indicated that passive smoking is associated
with an increased risk of premenopausal breast cancer
(Johnson et al. 2011; International Agency for Research
on Cancer 2012; Hanaoka et al. 2005). Most cohort stud-
ies have found no association for passive smoking (Inter-
national Agency for Research on Cancer 2012), whereas
one cohort study in Japan observed a significant inverse
association (Nishino et al. 2001). Although evidence re-
lated to hormone receptor subtype have been limited,
one case-control study found no association between
passive smoking and any of the joint hormone receptor
subtypes (Gammon et al. 2004). A recent cohort study
from the US indicated that postmenopausal women who
had never smoked, but who had been extensively ex-
posed to passive smoking, had a significantly increased
risk of breast cancer; however, analysis according to hor-
mone receptor subtype found no significant association
with any subtype (Luo et al. 2011). In the present study,
in terms of hormone receptor status, no association was
observed between passive smoking from husbands and
the risk of breast cancer. As there has been some vari-
ation in the estimated parameters of passive smoking
among previous studies and ours, it may be unreason-
able to compare the results directly. However, these
studies suggest that the impact of passive smoking on
breast cancer risk may not be so large for any tumor
subtype.
The present study had both strengths and limitations.
In hospital-based case-control studies like ours, some
methodological problems are likely to influence the re-
sults. First, we considered comparability between the
Table 6 Odds ratio (OR) according to passive smoking by menopausal and hormone receptor status
Premenopausala Postmenopausalb
Controls
ER+/PgR+ (n = 166) ER-/PgR- (n = 63)
Pheterogeneity
ER+/PgR+ (n = 262) ER-/PgR- (n = 137)
PheterogeneityCases OR 95% CI Cases OR 95% CI Controls Cases OR 95% CI Cases OR 95% CI
Passive smoking (husband’s smoking)
Never smoker 158 54 1 (Reference) 21 1 (Reference) 547 90 1 (Reference) 48 1 (Reference)
Current 288 81 0.96 0.61 - 1.52 35 0.96 0.51 - 1.81 486 85 1.19 0.85 - 1.68 52 1.28 0.83 - 1.97
Past 105 31 0.76 0.42 - 1.37 7 0.53 0.20 - 1.38 363 87 1.31 0.93 - 1.84 37 1.02 0.64 - 1.63
Ever 393 112 0.90 0.59 - 1.39 42 0.85 0.46 - 1.56 0.86 849 172 1.25 0.93 - 1.68 89 1.16 0.79 - 1.70 0.74
Analyzed for never-smoking married women.
aAdjusted by age, BMI, occupation, physical activity, age at menarche, age at first birth, family history of breast cancer in mother or sister, parity number, use of exogenous female hormone or oral contraceptives,
referrel status, year of recruitment, area of residence and alcohol drinking.
bAdjusted by age, BMI, occupation, physical activity, age at menarche, age at menopause, reson of menopause (natural, others including surgery), age at first birth, family history of breast cancer in mother or sister,
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http://www.springerplus.com/content/3/1/65cases and the controls. We selected the controls from
among patients admitted to the same hospital as the
cases. The participation rates were high for both cases
and controls. However, the distribution of risk factors
among the control subjects may have differed from that
in the general population. To improve comparability be-
tween the cases and controls, we excluded patients with
disease believed to have been related to smoking from
the controls. Consequently, the proportion of ever
smokers among the controls (16.6%) was comparable to
that in the general population of Miyagi Prefecture
(20.5%) (Report on Health Survey in Miyagi. Sendai:
Miyagi Prefecture 2005). Additionally, statistical analyses
were appropriately controlled for background character-
istics such as area of residence and referral status. Al-
though persistent bias might have existed, it is likely that
any problems with comparability would have been weak-
ened. Second, it is necessary to consider the possibility
of information bias. In particular, some individuals might
have changed their smoking habits after contracting dis-
eases, possibly resulting in misclassification of smoking
status. However, since the questionnaire was given to
each woman on the day of reservation for her first ad-
mission to the MCCH before any definite diagnosis or
treatment, any recall bias would likely have been min-
imal. Furthermore, as both cases and controls were se-
lected from among patients admitted to the same
hospital, the controls were not healthy subjects. There-
fore, even though their smoking habits might have chan-
ged, the patterns of change in the cases and controls
would have been comparable. Any information bias is
unlikely to have distorted our present results. Third, de-
tailed information on passive smoking was not available
in the present study. Only information about passive
smoking from husbands among married women was
included in the analysis. Due to the lack of data on ex-
posure to tobacco smoke during childhood and occupa-
tional passive smoking exposure, the role of passive
smoking might not have been fully evaluated.
One of the strengths of our study was that breast can-
cer risk factors such as reproductive factors, BMI and al-
cohol drinking were controlled for in the analysis. Thus,
our study evaluated the independent effects of smoking
on breast cancer risk. Some previous studies had not
been considered the confounding effects of such risk fac-
tors (Palmer and Rosenberg 1993; Nagata et al. 2006;
Johnson 2005). Another strength was the low rate of
missing data (8.2%) for hormone receptor status. Com-
pared with our present study, the rates of missing data
in some previous studies, including cohort studies, were
relatively high (Yoo et al. 1997; London et al. 1989).
In conclusion, the present case-control study found no
association between history of smoking (ever, never) and
breast cancer risk for any hormone receptor subtype.There was also no association between passive smoking
(ever, never) from husbands and the risk of breast can-
cer. However, detailed analysis of smoking-related mea-
sures showed that an early age at the start of smoking of
≤19 years was significantly associated with an increased
risk of postmenopausal ER-/PgR- cancer, suggesting that
early exposure to tobacco smoke may stimulate the de-
velopment of ER-/PgR- cancer. Other smoking-related
measures such as the number of cigarettes smoked per
day, the duration of smoking, and the number of pack-
years were not associated with breast cancer risk for any
hormone receptor subtype. Cigarette smoking, which
may be a preventable risk factor, has complicated effects
including direct carcinogenic and antiestrogenic effects.
Further studies including bigger, pooled cohort studies
are required to clarify the association of smoking with
breast cancer risk.
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